Emerging issues related to COVID-19 vaccination in patients with cancer

被引：0
作者：
Kamal S. Saini
Diogo Martins-Branco
Marco Tagliamento
Laura Vidal
Navneet Singh
Kevin Punie
Monika Lamba Saini
Isagani Chico
Giuseppe Curigliano
Evandro de Azambuja
Matteo Lambertini
机构：
[1] Covance Inc,Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine
[2] Institut Jules Bordet,Department of Medical Oncology, U.O. Clinica di Oncologia Medica
[3] University of Genova,Department of General Medical Oncology and Multidisciplinary Breast Centre, Leuven Cancer Institute
[4] IRCCS Ospedale Policlinico San Martino,Laboratory of Experimental Oncology
[5] Postgraduate Institute of Medical Education and Research,Istituto Europeo di Oncologia
[6] University Hospitals Leuven,undefined
[7] KU Leuven,undefined
[8] CellCarta,undefined
[9] IRCCS,undefined
[10] University of Milano,undefined
[11] Université Libre de Bruxelles (U.L.B.),undefined
来源：
Oncology and Therapy | 2021年 / 9卷
关键词：
Cancer; COVID-19; Efficacy; mRNA; SARS-CoV-2; Toxicity; Vaccine; Viral vector;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Coronavirus disease 2019 (COVID-19) has resulted in millions of deaths globally. The pandemic has had a severe impact on oncology care and research. Patients with underlying cancer are more vulnerable to contracting COVID-19, and also have a more severe clinical course following the infection. The rollout of COVID-19 vaccines in many parts of the world has raised hopes of controlling the pandemic. In this editorial, the authors outline key characteristics of the currently approved COVID-19 vaccines, provide a brief overview of key emerging issues such as vaccine-induced immune thrombotic thrombocytopenia and SARS-CoV-2 variants of concern, and review the available data related to the efficacy and side effects of vaccinating patients with cancer.
引用
收藏
页码：255 / 265
页数：10
相关论文
共 156 条
  • [1] Osuchowski MF(2021)The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity Lancet Respir Med 7 e432-e435
  • [2] Winkler MS(2020)Effect of the COVID-19 pandemic on cancer treatment and research Lancet Haematol 6 1357-1362
  • [3] Skirecki T(2020)Reimagining global oncology clinical trials for the postpandemic era: a call to arms JCO Glob Oncol 8 171-182
  • [4] Saini KS(2019)Radiation therapy during the coronavirus disease 2019 (covid-19) pandemic in Italy: a view of the nation’s young oncologists ESMO Open 2021 316-327
  • [5] de Las HB(2019)Cancer care during the spread of coronavirus disease (COVID-19) in Italy: young oncologists’ perspective ESMO Open 123 694-697
  • [6] de Castro J(2020)Cancer treatment and research during the COVID-19 pandemic: experience of the first 6 months Oncol Ther 51 657-662
  • [7] Saini KS(1990)SARS-CoV-2 vaccines for cancer patients: a call to action Eur J Cancer Oxf Engl 2020 43-50
  • [8] de Las HB(2020)Repurposing anticancer drugs for COVID-19-induced inflammation, immune dysfunction, and coagulopathy Br J Cancer 113 371-380
  • [9] Plummer R(2021)Coagulopathy, endothelial dysfunction, thrombotic microangiopathy and complement activation: potential role of complement system inhibition in COVID-19 J Thromb Thrombolysis 1318 657-672
  • [10] Meattini I(1990)Mortality in patients with cancer and coronavirus disease 2019: a systematic review and pooled analysis of 52 studies Eur J Cancer Oxf Engl 8 e163-e164
12345678910